Howe & Rusling Inc. Makes New $227,000 Investment in Cigna Group $CI

Howe & Rusling Inc. acquired a new position in Cigna Group (NYSE:CI) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 689 shares of the health services provider’s stock, valued at approximately $227,000.

Several other large investors also recently made changes to their positions in CI. Brighton Jones LLC increased its position in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares in the last quarter. ProShare Advisors LLC increased its position in shares of Cigna Group by 10.7% in the fourth quarter. ProShare Advisors LLC now owns 48,117 shares of the health services provider’s stock worth $13,287,000 after acquiring an additional 4,658 shares in the last quarter. Raiffeisen Bank International AG acquired a new stake in shares of Cigna Group in the fourth quarter worth $3,886,000. Rafferty Asset Management LLC increased its position in shares of Cigna Group by 11.3% in the fourth quarter. Rafferty Asset Management LLC now owns 31,551 shares of the health services provider’s stock worth $8,712,000 after acquiring an additional 3,199 shares in the last quarter. Finally, Snowden Capital Advisors LLC increased its position in shares of Cigna Group by 5.6% in the fourth quarter. Snowden Capital Advisors LLC now owns 4,229 shares of the health services provider’s stock worth $1,168,000 after acquiring an additional 226 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of CI stock opened at $302.71 on Friday. The firm has a market cap of $80.80 billion, a P/E ratio of 16.52, a P/E/G ratio of 0.90 and a beta of 0.48. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. Cigna Group has a 1-year low of $256.89 and a 1-year high of $370.83. The firm has a fifty day moving average of $295.47 and a two-hundred day moving average of $312.00.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. During the same period last year, the business earned $6.72 EPS. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Thursday, September 4th. Cigna Group’s dividend payout ratio (DPR) is presently 32.97%.

Insider Activity

In other news, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on CI shares. Guggenheim reaffirmed a “buy” rating and set a $350.00 price target (down from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $365.00 price target on shares of Cigna Group in a report on Tuesday, August 26th. Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the company a “buy” rating in a report on Tuesday, August 5th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $371.00 price target on shares of Cigna Group in a report on Thursday, June 26th. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $374.76.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.